TG Therapeutics Reports Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 2019 AACR Annual Meeting

Drug Category: Array
Conference Category: Array
Lead Author: Fowler N, et al.
Published Date: 01/04/2019
Download Link: /FINAL%20TGTX%20MZL%20AACR%20ORAL%20PRESENTATION%20FOWLER%202019.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top